| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.2M | +313.9% |
| Cost of Revenue | $22.8M | +247.2% |
| Gross Profit | $14.4M | +494.4% |
| R&D Expense | $430K | +225.8% |
| SG&A Expense | $4.5M | +387.5% |
| Operating Income | -$53.3M | -180.5% |
| Interest Expense | $1.6M | +20.4% |
| Pre-tax Income | -$54.2M | -152.4% |
| Income Tax | -$1.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.5M | -74.6% |
| Accounts Receivable | $6.9M | +28.7% |
| Inventory | $10.1M | +233.0% |
| Current Assets | $31.2M | -35.0% |
| Total Assets | $81.0M | -5.3% |
| Current Liabilities | $17.4M | +185.1% |
| Total Liabilities | $24.6M | +187.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.9M | +23.9% |
| Capital Expenditures | $1.3M | -67.5% |
| Investing Cash Flow | -$15.8M | -8.6% |
| Financing Cash Flow | $4.4M | -92.4% |
| Free Cash Flow | -$17.2M | +30.9% |
| -1469.4% |
| Net Income | -$52.6M | -146.4% |
| Stockholders' Equity |
| $56.8M |
| -26.4% |